Home / Resources / Why CBG Costs More to Manufacture

Why CBG Costs More to Manufacture
And Why That's Your Margin Story

CBG isolate costs more than CBD isolate at every step from the field to the gummy. That cost structure is not a liability — it is the supply-side justification for a retail price premium that CBD can no longer command.

1. Yield Differences — CBG Biomass per Acre

Hemp is primarily a CBD plant in its current commercial cultivar landscape. The major certified hemp varieties were bred and selected over the past decade to maximize CBD yield per acre. A mature hemp plant at harvest from a CBD-optimized cultivar might carry 10–15% CBD by dry weight — an efficient extraction target.

CBG operates differently in the plant's biochemistry. CBGA (cannabigerolic acid) is the biosynthetic precursor to CBD, THC, CBN, and essentially all other major cannabinoids. In a mature hemp plant, enzymes have converted most of the CBGA into those downstream compounds. By harvest, the remaining CBG concentration in a standard CBD hemp plant is typically 1% or less — sometimes much less. That is one-tenth to one-fifteenth the extractable concentration of CBD in the same plant.

To produce CBG at useful extraction concentrations, growers have two options: harvest the plant early (before enzymatic conversion runs), or grow a CBG-specific cultivar that has been bred with suppressed enzyme expression to preserve CBGA in the plant longer. Early harvest reduces per-acre biomass yield. CBG-specific cultivars are less widely available, carry higher seed costs, and have shorter track records in the field compared to established CBD cultivars. Either approach means more acres and more farm input cost per kilogram of CBG isolate produced.

2. Extraction Differences

Once the biomass is harvested, extraction of CBG isolate follows a similar CO2 or ethanol extraction process to CBD — but the starting concentration in the plant material is so much lower that the processor has to run more material through the same equipment to get the same output weight.

In practical terms: a CBD extractor who can produce 1 kg of CBD crude from a given volume of biomass might need five to ten times that volume of CBG biomass to produce 1 kg of CBG crude. More biomass, more solvent or CO2, more equipment time, more energy, more labor. The cost per kilogram of crude CBG extract is proportionally higher at every step of the extraction run.

Post-extraction isolation — the chromatography and winterization steps that take crude extract to finished isolate — adds another cost layer specific to CBG. Because CBG coexists with other cannabinoids in the crude and the starting concentrations are lower, isolation runs require more processing to achieve high-purity CBG isolate. The certificate of analysis for finished CBG isolate typically shows 98%+ purity — reaching that number costs more from a lower-concentration starting point.

3. The Supply Chain Layer

CBD isolate is a commodity. There are dozens of brokers, dozens of domestic and international producers, and real spot-market competition that has driven CBD isolate prices to a fraction of where they were in 2019. A buyer can source CBD isolate from multiple competing suppliers and compare prices on a weekly basis.

CBG isolate has a thinner supply chain. There are fewer CBG-specific cultivar programs, fewer dedicated CBG extraction operations, and fewer isolate brokers competing on price. That thinner supply creates less downward price pressure. A manufacturer sourcing CBG isolate is working with fewer supplier relationships and less leverage on spot pricing compared to CBD.

The supply chain also has more quality variance. Because CBG-specific cultivation and extraction is less mature as an industry practice, COA quality, potency consistency, and batch-to-batch reliability vary more across suppliers than the CBD isolate market. Steve's Goods sources CBG isolate from a short list of domestic suppliers with established COA histories — qualifying new CBG isolate suppliers is more time-consuming and costly than qualifying a new CBD isolate supplier.

For wholesale buyers, the implication is that CBG isolate pricing does not have the same floor-compression trajectory that CBD isolate has experienced. CBG input costs are unlikely to drop to commodity CBD levels in the near term because the supply-side conditions that drove CBD commoditization — widespread cultivar development, scaled extraction infrastructure, aggressive broker competition — have not yet materialized for CBG.

4. How to Talk the Cost Into a Retail Price the Buyer Accepts

Most retail buyers understand supply-and-demand pricing. The conversation that works is direct and short: "CBG costs more per kilogram to produce than CBD. That cost flows through to a higher wholesale price per gummy. The reason it works at retail is that CBG carries a premium price point that CBD can no longer support in most markets."

The retail buyer's objection you need to preempt is: "My customers are price-sensitive." The response: "Your CBD customers are price-sensitive. Your nootropic customers are not. CBG lives on the nootropic shelf, not the CBD shelf. A 30-count CBG gummy at $45 is not competing against $25 CBD — it is competing against a $38 lion's mane supplement and winning on the hemp-plus-focus story."

The specific framing that converts skeptical buyers: "I'm not asking you to sell CBG as a premium CBD. I'm asking you to sell it as a different compound for a different occasion at a different shelf position. The premium price is not a cost problem — it's the product positioning." That frame shifts the conversation from margin math (cost vs. price) to category positioning (which shelf, which customer, which use case).

See the full CBG vs CBD margin math breakdown for per-unit examples across the 5mg, 10mg, and 20mg dosing tiers.

5. Where the Margin Advantage Actually Lives

The margin advantage in CBG is not in the gross margin percentage per gummy — at equivalent retail prices, a 10mg CBG gummy and a 10mg CBD gummy would show similar gross margin percentages. The advantage is in the retail price ceiling.

CBD has a retail price ceiling that has compressed over the past four years as the category commoditized. A 30-count 25mg CBD gummy at $35 retail is a competitive price point. At $45 it faces buyer resistance in most markets. At $55 it is a hard sell for standard CBD positioning.

CBG, positioned correctly in the focus and nootropic aisle, does not have the same ceiling. A 30-count 20mg CBG gummy at $54–$64 retail is within the normal range for the nootropic aisle and does not face the same consumer price resistance. Because wholesale cost is higher but retail price ceiling is also higher — and because the retail price ceiling is what determines gross margin dollars, not percentages — the margin per unit in dollar terms is competitive with CBD despite the higher cost of goods.

The additional margin lever is reorder rate. Wholesale buyers who run CBG in a well-positioned daytime set report that the category's sell-through rate in established accounts is strong enough to justify larger reorders at the Growth tier ($0.21/gummy) — where the per-unit cost drops while the retail price holds. That is where the full margin advantage crystallizes: not at the first Starter-tier order, but at the first reorder when the volume tier shifts.

See full wholesale pricing tiers and CBG formulation options to model your specific volume and margin scenario.

These statements have not been evaluated by the FDA. Our products are not intended to diagnose, treat, cure, or prevent any disease. All CBG products are hemp-derived. Hemp-derived, state rules vary — check your state.